Titlebook: Vascular Perfusion in Cancer Therapy; Konrad Schwemmle,Karl Aigner Book 1983 Springer-Verlag Berlin Heidelberg 1983 Zytostatikum.alcohol.c

Decibel

Arterial Infusion Chemotherapy for Hepatic Metastasestment by itself is preferred for primary hepatic tumors, bulky solitary metastases, and smaller hepatic metastases limited to one lobe (Pettavel and Meyer 1979). In addition, the excision of one or even several metastases is generally preferable before instituting chemotherapy. The logical basis for

AVANT

MERIT

sperse

Improved Quality of Life with an Implantable Pump for Liver Perfusion to prolong life. Survival time with liver metastases averages 4–6 months after diagnosis is established. Systemic treatment with cytostatic agents has not shown any marked effect. For example, Oberfield et al. (1979) achieved an 8.5-month survival time in his patients by liver perfusion, but the ex

Insatiable

健談

Isolated Liver Perfusion in Dogssfield et al. 1971; Misra et al. 1977; Ramming et al. 1976; Taylor 1978). The liver is thus supplied with high doses of cytostatics via the arterial or portal system. However, after passing through the liver these drugs enter the systemic circulation and cause the familiar side effects. Moreover, th

都相信我的話

degradation

–scent

Prolonged and Continuous Percutaneous Intra-Arterial Hepatic Infusion Chemotherapy in Advanced Metasery is not suitable for bilateral disease. Over the past 10–15 years we have reported our experience with surgical placement of the catheter, with increases in response and survival (Cady and Oberfield 1972, 1974; Oberfield 1974; Sullivan and Zurek 1965; Watkins et al. 1970).

協(xié)議